Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

22.2%

2 terminated/withdrawn out of 9 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

100%

5 of 5 completed trials have results

Key Signals

1 recruiting5 with results

Enrollment Performance

Analytics

N/A

6(85.7%)

Phase 3

1(14.3%)

7Total

N/A(6)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT04294446Terminated

Post-market Study of the Biodesign Hernia Graft

Role: lead

NCT03632031Not ApplicableCompleted

Treatment of Wounds Using Oasis® ECM

Role: lead

NCT04079348Not ApplicableRecruiting

Oasis Donor Site Wounds Post-Market Study

Role: lead

NCT00610207Not ApplicableTerminated

Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa Graft

Role: collaborator

NCT00393887Not ApplicableCompleted

Inguinal Hernia Study Using Biodesign IHM

Role: collaborator

NCT00545441Not ApplicableCompleted

A Randomized Clinical Trial Comparing Surgisis AFP to Advancement Flap for the Repair of Anal Fistulas

Role: collaborator

NCT00274625Not ApplicableCompleted

Evaluation of Surgisis Gold Graft for Incision Reinforcement After Open Bariatric Surgery

Role: collaborator

NCT00647569Phase 3Completed

Trial of Collagen Mesh for Prevention of Ventral Hernia After Surgery for Advanced Pelvic Cancer

Role: collaborator

NCT00786084Unknown

Study of Paraesophageal Hernia Repair With Small Intestine Submucosa

Role: collaborator

All 9 trials loaded